NCT01488487 Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT01487785 Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients Status COMPLETED Phase PHASE1
NCT01487460 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients Status COMPLETED Phase PHASE1
NCT01484860 Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy Status TERMINATED Phase PHASE2
NCT01484197 A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device Status COMPLETED Phase PHASE2
NCT01484041 Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01483014 Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST) Status COMPLETED Phase PHASE2
NCT01482156 Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01482143 Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS) Status COMPLETED Phase PHASE1
NCT01480791 Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries Status WITHDRAWN Phase PHASE2
NCT01479595 A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma Status COMPLETED Phase PHASE2
NCT01478373 Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib Status COMPLETED Phase PHASE2
NCT01478360 Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma Status TERMINATED Phase PHASE2
NCT01474681 Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT01474421 Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease Status COMPLETED Phase PHASE2
NCT01473901 A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1
NCT01471847 A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab Status COMPLETED Phase PHASE1